PAPER Wakita H, Takahashi Y, Masuzugawa S, Miyasaka H, Sonoda S, Shindo A, Tomimoto H
SEARCH RESULTS
331712 RESULTS
PAPER Yong J, Song J
CaMKII activity and metabolic imbalance-related neurological diseases: Focus on vascular dysfunction, synaptic plasticity, amyloid beta accumulation, and lipid metabolism.
Biomed Pharmacother. 2024 Apr 30;175:116688. PubMed: 38692060PAPER Thaler A, Livne V, Rubinstein E, Omer N, Faust-Socher A, Cohen B, Giladi N, Shirvan JC, Cedarbaum JM, Gana-Weisz M, Goldstein O, Orr-Urtreger A, Alcalay RN, Mirelman A
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.
Parkinsonism Relat Disord. 2024 Apr 16;123:106970. PubMed: 38691978PAPER Zhu Z, Zhong X, Wang B, Lu H, Li L
Probing Protein Structural Changes in Alzheimer's Disease via Quantitative Cross-linking Mass Spectrometry.
Anal Chem. 2024 May 1; PubMed: 38690851PAPER Schreiner SJ, Van Bergen JM, Gietl AF, Buck A, Hock C, Pruessmann KP, Henning A, Unschuld PG
Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old age.
Alzheimers Dement (Amst). 2024;16(2):e12587. Epub 2024 Apr 30 PubMed: 38690510PAPER
2024 Alzheimer's disease facts and figures.
Alzheimers Dement. 2024 Apr 30; PubMed: 38689398PAPER Agarwal T, Manandhar S, B HK, Famurewa AC, Gurram PC, Suggala RS, Sankhe R, Mudgal J, Pai KS
Oxyresveratrol-β-cyclodextrin mitigates streptozotocin-induced Alzheimer's model cognitive impairment, histone deacetylase activity in rats: in silico & in vivo studies.
Sci Rep. 2024 Apr 30;14(1):9897. PubMed: 38688962PAPER Teralı K, Ozbeyli D, Yiğit-Hanoğlu D, Başer KH, Şener G, Aykac A
A comprehensive assessment of the cholinergic-supporting and cognitive-enhancing effects of Rosa damascena Mill. (Damask rose) essential oil on scopolamine-induced amnestic rats.
Brain Behav. 2024 May;14(5):e3507. PubMed: 38688895PAPER Quek YE, Fung YL, Bourgeat P, Vogrin SJ, Collins SJ, Bowden SC
Combining neuropsychological assessment and structural neuroimaging to identify early Alzheimer's disease in a memory clinic cohort.
Brain Behav. 2024 May;14(5):e3505. PubMed: 38688879PAPER Xu L, Wu X, Zhao S, Hu H, Wang S, Zhang Y, Chen J, Zhang X, Zhao Y, Ma R, Huang F, Shi L
Harnessing Nanochaperone-Mediated Autophagy for Selective Clearance of Pathogenic Tau Protein in Alzheimer's Disease.
Adv Mater. 2024 Apr 30;:e2313869. PubMed: 38688523PAPER Gutiérrez-de Pablo V, Poza J, Maturana-Candelas A, Rodríguez-González V, Tola-Arribas MÁ, Cano M, Hoshi H, Shigihara Y, Hornero R, Gómez C
Exploring the disruptions of the neurophysiological organization in Alzheimer's disease: An integrative approach.
Comput Methods Programs Biomed. 2024 Apr 24;250:108197. PubMed: 38688139PAPER Siemeling O, Slingerland S, van der Zee S, van Laar T
Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation.
BMC Neurol. 2024 May 1;24(1):146. PubMed: 38693511PAPER Hernández-Lorenzo L, García-Gutiérrez F, Solbas-Casajús A, Corrochano S, Matías-Guiu JA, Ayala JL
Genetic-based patient stratification in Alzheimer's disease.
Sci Rep. 2024 Apr 30;14(1):9970. PubMed: 38693203PAPER Karlsson L, Vogel J, Arvidsson I, Åström K, Janelidze S, Blennow K, Palmqvist S, Stomrud E, Mattsson-Carlgren N, Hansson O
Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases.
Nat Commun. 2024 May 1;15(1):3676. PubMed: 38693142PAPER Tartwijk FW, Wunderlich LC, Mela I, Makarchuk S, Jakobs MA, Qamar S, Franze K, Schierle GS, George-Hyslop PH, Lin JQ, Holt CE, Kaminski CF
Mutation of the ALS/FTD-associated RNA-binding protein FUS affects axonal development.
J Neurosci. 2024 May 1; PubMed: 38692734Current Filters
No filters selected